ORAMED PHARMACEUTICALS INC.: cash_and_equivalents
| Value | {"amount": 57414000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2021-05-31) |
| Status | current |
| Entity | ORAMED PHARMACEUTICALS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:50:45.956610+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b9a1f946-a8f4-43fe-a8e0-c77fee5d3755
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-036889Retrieved: 2026-08-19T11:50:45.956610+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001176309/cash-and-equivalents/2021-05-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b9a1f946-a8f4-43fe-a8e0-c77fee5d3755
History
- no predecessors — first report